The high mutation frequency of EGFR in various human cancers inspired the hypothesis that EGFR could serve as a potential biomarker; however, the deterministic interaction relationship and mechanism between EGFR and TIME has not been fully reported (7, 71). Here, EGFR is linked to cancer.